{
    "SPADE_UN_26807": {
        "Sequence Information": {
            "Peptide Name": "Ac-LVTX-8-NHNH2",
            "Sequence": "IWLTALKFLGKNLGKHLAKQQLSKL",
            "Sequence Length": 25,
            "Biological Activity": [
                "Anticancer"
            ],
            "Binding Target": "1. Lipid Bilayer\n2. Mitochondrial membrane",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [],
            "Literature": [
                {
                    "Title": "Efficient synthesis and anticancer evaluation of spider toxin peptide LVTX-8-based analogues with enhanced stability",
                    "Pubmed ID": "36907048",
                    "Reference": "Bioorg Chem. 2023;134:106451",
                    "Author": "Chi QN, Jia SX, Yin H, Wang LE, Fu XY, Ma YN, Sun MP, Qi YK, Li Z, Du SS",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/36907048"
                }
            ],
            "Mass": 2849.46,
            "PI": 10.6,
            "Net Charge": 6,
            "Hydrophobicity": 0.04,
            "Frequent Amino Acids": "LKA",
            "Absent Amino Acids": "CDEMOPRUVY",
            "Basic Residues": 6,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 11,
            "Polar Residues": 14,
            "Positive Residues": 6,
            "Negative Residues": 0,
            "SPADE ID": "SPADE_UN_26807",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_23083",
                    "Similarity": 1.0,
                    "Sequence": "IWLTALKFLGKNLGK"
                },
                {
                    "SPADE_ID": "SPADE_UN_23084",
                    "Similarity": 1.0,
                    "Sequence": "IWLTKALKFLGKNLGK"
                },
                {
                    "SPADE_ID": "SPADE_UN_23085",
                    "Similarity": 1.0,
                    "Sequence": "IWLTKALKFLGKNLGK"
                }
            ],
            "Hemolytic Activity": "",
            "Target Organism": "Mouse lymphoma A20(IC50=0.71±0.02µM),Human histiocytic lymphoma U-937(IC50=0.29±0.09µM),Human Lymphoblast Daudi cells(IC50=0.65±0.39µM),Human ovarian adenocarcinoma COC1(IC50=1.48±0.25µM),Human hepatocellular carcinoma HepG2(IC50=6.73±2.68µM),Mouse Hepatoma Hepa1-6(IC50=5.35±0.38µM),Human ovarian carcinoma ES-2(IC50=11.03±0.86µM)"
        }
    }
}